These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 3523546)

  • 1. [The detection of antibodies against D-penicillamine. 3. Detection of antibodies against D-penicillamine in the serum of patients with Wilson's disease treated with D-penicillamine--preliminary results].
    Trautmann B; Storch W
    Pharmazie; 1986 Feb; 41(2):126-7. PubMed ID: 3523546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Serious side effects with D-penicillamine therapy for Wilson's disease].
    Storch W; Lössner J; Ruchholtz U
    Psychiatr Neurol Med Psychol (Leipz); 1979 Sep; 31(9):531-8. PubMed ID: 161403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of antibodies against D-penicillamine. 2. Experimental animal proof of production of antibodies against D-penicillamine using indirect immunofluorescence with a DASS system].
    Storch W; Trautmann B; Nuhn P; Kessler KH
    Pharmazie; 1984 Nov; 39(11):752-3. PubMed ID: 6397758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [immunohistologic findings of kidney biopsies in Wilson's disease].
    Storch W; Ditscherlein G; Lange E; Lössner J
    Z Urol Nephrol; 1980 Mar; 73(3):181-90. PubMed ID: 7434982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunologic studies with the lymphocyte transformation test on the side effects of D-penicillamine therapy in Wilson's disease].
    Storch W; Berger H
    Z Gesamte Inn Med; 1980 Jul; 35(13):567-70. PubMed ID: 7445606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of long-term treatment with d-penicillamine on the humoral immune response in patients with Wilson's disease.
    Czlonkowska A
    Mater Med Pol; 1976; 8(1):48-50. PubMed ID: 1263584
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease.
    Hanukoglu A; Curiel B; Berkowitz D; Levine A; Sack J; Lorberboym M
    J Pediatr; 2008 Dec; 153(6):864-6. PubMed ID: 19014823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibodies against D-penicillamine in primary biliary cirrhosis].
    Storch W
    Immun Infekt; 1990 Feb; 18(1):22-3. PubMed ID: 2179124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Trientin in Wilson's disease. Therapeutic possibilities in patients who cannot tolerate penicillamine].
    Ritland S
    Tidsskr Nor Laegeforen; 1987 Aug; 107(22):1770-1. PubMed ID: 3660361
    [No Abstract]   [Full Text] [Related]  

  • 10. [D-penicillamine-induced IgA deficiency in the therapy of Wilson's disease].
    Ibel H; Feist D; Endres W; Belohradsky BH
    Klin Padiatr; 1990; 202(6):427-9. PubMed ID: 2266710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
    Haslam RH; Sass-Kortsak A; Stout W; Berg M
    Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Oral zinc in Wilson disease--an alternative to D-penicillamine].
    Ramadori G; Keidl E; Hütteroth T; Dormeyer HH; Manns M; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1985 Jan; 23(1):25-9. PubMed ID: 4060799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of penicillamine and zinc on iron metabolism in Wilson's disease.
    Medici V; Di Leo V; Lamboglia F; Bowlus CL; Tseng SC; D'Incà R; Irato P; Burra P; Martines D; Sturniolo GC
    Scand J Gastroenterol; 2007 Dec; 42(12):1495-500. PubMed ID: 17994470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [On the therapeutic combination of S-adenosylmethionine with D-penicillamine in Wilson's disease].
    Gasbarrini G; Miglio F; Corazza GR; Stefanini GF
    Minerva Med; 1975 May; 66(33):1600-4. PubMed ID: 1143693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
    Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
    Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The detection of antibodies against D-penicillamine. 1. Coupling of D-penicillamine to various carriers and generation of antibodies against D-penicillamine conjugate].
    Nuhn P; Kessler KH; Trautmann B; Storch W
    Pharmazie; 1984 Oct; 39(10):702-3. PubMed ID: 6084250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermal alterations in patients with Wilson's disease treated with D-penicillamine.
    Pasquali Ronchetti I; Quaglino D; Baccarani Contri M; Hayek J; Galassi G
    J Submicrosc Cytol Pathol; 1989 Jan; 21(1):131-9. PubMed ID: 2702608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On hepatolenticular degeneration (Wilson's disease). II. Treatment of 2 cases of Wilson's disease for 8 months with D-penicillamine].
    Germinario L; Campanella G; D'Addabbo A
    Acta Neurol (Napoli); 1971; 26(4):423-35. PubMed ID: 5132824
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pregnancy and delivery in a woman with Wilson's disease (degeneratio hepatoleuticularis)].
    Pierzchała W; Zamłyński J; Rzempołuch J
    Pol Tyg Lek; 1994 Feb 21-28; 49(8-9):200-1. PubMed ID: 8084826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Nephrotic syndrome after treatment with penicillamine in Wilson's disease].
    Hampel R; Meng W; Kallwellis G
    Z Gesamte Inn Med; 1976 Jul; 31(13):507-11. PubMed ID: 960872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.